137 related articles for article (PubMed ID: 27518679)
21. [Therapeutic strategies for the management of gliomas].
Hottinger AF; Stupp R
Rev Neurol (Paris); 2008; 164(6-7):523-30. PubMed ID: 18565350
[TBL] [Abstract][Full Text] [Related]
22. Successful combination chemotherapy (vincristine, procarbazine, etoposide, and prednisolone) in the treatment of inoperable, radioresistant low grade astrocytoma: a case report.
Maipang MVasiknanonte P; Janjindamai SHirunpat S
J Med Assoc Thai; 2000 Dec; 83(12):1525-9. PubMed ID: 11253894
[TBL] [Abstract][Full Text] [Related]
23. [Genetic analysis and individualized therapy for diffuse glioma].
Watanabe T; Yoshino A; Katayama Y
No Shinkei Geka; 2005 Jun; 33(6):537-53. PubMed ID: 15952303
[No Abstract] [Full Text] [Related]
24. Medical Research Council adjuvant trial in high-grade gliomas.
Chamberlain MC; Jaeckle KA
J Clin Oncol; 2001 Oct; 19(19):3997-9. PubMed ID: 11579124
[No Abstract] [Full Text] [Related]
25. Clinicopathological study of oligodendroglial tumors: the effectiveness of interferon beta, ACNU/MCNU, and radiation (IAR/IMR) for anaplastic tumors.
Wakabayashi T; Kajita Y; Hatano N; Thompson T; Nagasaka T; Yoshida J
Brain Tumor Pathol; 2000; 17(1):29-33. PubMed ID: 10982007
[TBL] [Abstract][Full Text] [Related]
26. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.
Dazzi C; Cariello A; Giannini M; Del Duca M; Giovanis P; Fiorentini G; Leoni M; Rosti G; Turci D; Tienghi A; Vertogen B; Zumaglini F; De Giorgi U; Marangolo M
Anticancer Res; 2000; 20(1B):515-8. PubMed ID: 10769716
[TBL] [Abstract][Full Text] [Related]
27. Clinical, pathological and therapeutic aspects of oligodendroglioma.
Brandes AA; Fiorentino MV
Cancer Treat Rev; 1998 Apr; 24(2):101-11. PubMed ID: 9728420
[No Abstract] [Full Text] [Related]
28. Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas.
Cho KH; Kim JY; Lee SH; Yoo H; Shin SH; Moon SH; Kim TH; Shin KH; Yoon M; Lee DH; Pyo HR
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):390-7. PubMed ID: 20097489
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy for brain tumor].
Takahashi H; Tanaka R
Nihon Rinsho; 2005 Sep; 63 Suppl 9():452-5. PubMed ID: 16201563
[No Abstract] [Full Text] [Related]
30. Salvage temozolomide for prior temozolomide responders.
Franceschi E; Omuro AM; Lassman AB; Demopoulos A; Nolan C; Abrey LE
Cancer; 2005 Dec; 104(11):2473-6. PubMed ID: 16270316
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage.
Hofer S; Herrmann R
J Cancer Res Clin Oncol; 2001 Feb; 127(2):91-5. PubMed ID: 11216919
[TBL] [Abstract][Full Text] [Related]
32. Should concomitant and adjuvant treatment with temozolomide be used as standard therapy in patients with anaplastic glioma?
Siker ML; Chakravarti A; Mehta MP
Crit Rev Oncol Hematol; 2006 Nov; 60(2):99-111. PubMed ID: 17027279
[TBL] [Abstract][Full Text] [Related]
33. Successful chemotherapy for newly diagnosed aggressive oligodendroglioma.
Macdonald DR; Gaspar LE; Cairncross JG
Ann Neurol; 1990 May; 27(5):573-4. PubMed ID: 2360797
[TBL] [Abstract][Full Text] [Related]
34. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy.
Glass J; Hochberg FH; Gruber ML; Louis DN; Smith D; Rattner B
J Neurosurg; 1992 May; 76(5):741-5. PubMed ID: 1564535
[TBL] [Abstract][Full Text] [Related]
35. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
[TBL] [Abstract][Full Text] [Related]
36. Radiation therapy of primary tumors.
Sheline GE
Semin Oncol; 1975 Mar; 2(1):29-42. PubMed ID: 188200
[No Abstract] [Full Text] [Related]
37. Glioma treatment, radionecrosis, and growth factors. In regard to Levin et al., IJROBP 2002;53:58-66.
Nieder C
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):849; author reply 849. PubMed ID: 12573773
[No Abstract] [Full Text] [Related]
38. [Chemotherapy of malignant brain tumors].
Stieglmayr FS
Wien Med Wochenschr; 1973 Nov; 123(44):637-42. PubMed ID: 4584464
[No Abstract] [Full Text] [Related]
39. Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading.
Levin VA
Neuro Oncol; 1999 Jan; 1(1):69-80. PubMed ID: 11550304
[TBL] [Abstract][Full Text] [Related]
40. Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities.
Buckner JC; Gesme D; O'Fallon JR; Hammack JE; Stafford S; Brown PD; Hawkins R; Scheithauer BW; Erickson BJ; Levitt R; Shaw EG; Jenkins R
J Clin Oncol; 2003 Jan; 21(2):251-5. PubMed ID: 12525516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
